Skip to main content
. 2016 Jan 27;18(4):549–556. doi: 10.1093/neuonc/nov326

Table 2.

Outcome by extent of resection

Extent of Resection
P
Gross Total Resection
Incomplete
Patients Events Time, mo (95% CI) Patients Events Time, mo (95% CI)
Median PFS2 40 37 3.5 (2.0–5.1) 19 19 1.9 (1.3–3.5) .016
Median PRS 40 34 12.9 (11.5–18.2) 19 18 6.5 (3.6–9.9) <.001
Rate, % (95% CI) Rate, % (95% CI)
PFS2 at 6 mo 39 29 25.6 (11.3–40.0) 18 16 11.1 (5.0–27.2) .063
Survival rate at 12 mo from first study drug administration 39 16 59.0 (42.8–75.1) 18 15 16.7 (2.4–35.7) <.001